SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-115092
Filing Date
2022-04-22
Accepted
2022-04-22 16:06:01
Documents
7
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d221989ddef14a.htm DEF 14A 344413
2 GRAPHIC g221989g15l77.jpg GRAPHIC 1494
3 GRAPHIC g221989g50c16.jpg GRAPHIC 51277
4 GRAPHIC g221989g55j43.jpg GRAPHIC 3256
5 GRAPHIC g221989g56q65.jpg GRAPHIC 31419
6 GRAPHIC g221989g77w57.jpg GRAPHIC 4469
7 GRAPHIC g221989snap2.jpg GRAPHIC 1795
  Complete submission text file 0001193125-22-115092.txt   475324
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38529 | Film No.: 22845498
SIC: 2834 Pharmaceutical Preparations